表紙
市場調査レポート

脳性麻痺:主要8市場の予測 2015-2025年

Cerebral Palsy Forecast in 8 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 345244
出版日 ページ情報 英文 48 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
脳性麻痺:主要8市場の予測 2015-2025年 Cerebral Palsy Forecast in 8 Major Markets 2015-2025
出版日: 2015年11月17日 ページ情報: 英文 48 Pages
概要

脳性麻痺は単一の疾患ではないために正確な定義を欠いていますが、運動障害・姿勢異常を含む非進行性の脳病変を説明する包括的な用語は初期段階で指摘されています。脳性麻痺を引き起こす正確な病理学的メカニズムとプロセスの多くは明らかになっていません。しかし、早産、妊娠中の感染症や放射線への暴露、および出生後の頭部外傷は脳性麻痺を発症する危険要因と関連付けられています。

当レポートでは、主要8市場 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本) における脳性麻痺の現在の患者数 (性別、年齢コホート別) について調査分析し、現在の有病率のほか、疾患の概要、危険因子、疾患の診断と予後、主な症状や合併症など、体系的な情報を提供しています。

図表

イントロダクション

病因

危険因子と予防

疾患の診断

変異:地域/民族別

疾患予後と臨床経過

疾患に関連する主な合併症/特徴

患者数を定量化する手法

脳性麻痺の有病率トップライン

脳性麻痺の主な特徴

  • 運動症状の種類
  • 脳性麻痺:トポグラフィックタイプ
  • 脳性麻痺寛患者のGMFCSレベル
  • 脳性麻痺患者のBFMFレベル
  • 脳性麻痺の発症のタイミング
  • 出生後脳性麻痺の原因
  • 出生時の妊娠期間
  • 脳性麻痺患者の歩行能力
  • 脳性麻痺患者の神経学的併存疾患
  • 脳性麻痺における知的障害
  • 脳性麻痺患者における感覚障害
  • 身体障害
  • 脳性麻痺患者が持つ先天性奇形

略語

関連出版

患者ベースのオンラインデータベース

患者ベースの製品

価格のオンラインデータ・プラットフォーム

参考文献

付録

目次
Product Code: CPLS0011115

image1

Cerebral Palsy lacks a precise definition as it is not a single disease, but an umbrella term describing non-progressive brain lesions involving motor or postural abnormalities that are noted in early development. The exact pathological mechanisms and processes that cause Cerebral Palsy are largely unknown. However, premature birth, exposure to infection or radiation during pregnancy and post-natal head injuries are all associated risk factors in developing Cerebral Palsy.


This report provides the current prevalent population for Cerebral Palsy across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Cerebral Palsy have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Cerebral Palsy include:

  • Low weight at birth
  • Premature birth (pre-term)
  • Epilepsy and seizures
  • Sensory impairment
  • Congenital malformations

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Cerebral Palsy's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Cerebral Palsy and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Cerebral Palsy's prevalent population.
  • Identify sub-populations within Cerebral Palsy which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Cerebral Palsy patients.

Coverage

image2

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Co-morbid Conditions /Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Cerebral Palsy
  • Main Features of Cerebral Palsy
    • Type of Motor Symptoms
    • Cerebral Palsy by topographic type
    • GMFCS Level in Cerebral Palsy Patients
    • BFMF Level in Cerebral Palsy Patients
    • Timing of onset of Cerebral Palsy
    • Cause of post-natal Cerebral Palsy
    • Gestational age at time of birth
    • Walk ability in patients with Cerebral Palsy
    • Neurological Comorbidites in Cerebral Palsy Patients
    • Intellectual Deficit in Cerebral Palsy
    • Sensory deficits in Cerebral Palsy Patients
    • Orthopaedic Impairments
    • Congenital malformations in patients with Cerebral Palsy
  • Abbreviations and Acronyms used in the Report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • Classification systems used to describe cerebral palsy
  • Prevalence of Cerebral Palsy, total (000s)
  • Prevalence of Cerebral Palsy, males (000s)
  • Prevalence of Cerebral Palsy, females (000s)
  • Type of motor symptoms in Cerebral Palsy patients, total (000s)
  • Topography type of Cerebral Palsy patients, total (000s)
  • GMFCS level in Cerebral Palsy patients, total (000s)
  • BFMF level in Cerebral Palsy patients, total (000s)
  • Cerebral Palsy patients with severely impaired upper limb function, total (000s)
  • Cerebral Palsy patients with difficulties feeding by mouth, total (000s)
  • Timing of onset of Cerebral Palsy, total (000s)
  • Cause of Cerebral Palsy in post-natal patients, total (000s)
  • Cerebral Palsy caused by meningitis or encephalitis, total (000s)
  • Gestational age at time of birth for Cerebral Palsy patients, total (000s)
  • Walking ability of Cerebral Palsy patients, total (000s)
  • Epilepsy in Cerebral Palsy patients, total (000s)
  • Active seizure in Cerebral Palsy patients, total (000s)
  • Severe intellectual deficit in Cerebral Palsy patients, IQ < 50, total (000s)
  • Intellectual deficit in Cerebral Palsy patients, IQ 50-70, total (000s)
  • Visual impairment in Cerebral Palsy patients, total (000s)
  • Severe visual impairment in Cerebral Palsy patients, total (000s)
  • Hearing loss in Cerebral Palsy patients, total (000s)
  • Severe hearing loss in Cerebral Palsy patients, total (000s)
  • Hip sub-dislocation in Cerebral Palsy patients, total (000s)
  • Equinus in Cerebral Palsy patients, total (000s)
  • Scoliosis in Cerebral Palsy patients, total (000s)
  • Number of Cerebral Palsy patients with congenital malformations, total (000s)
  • Number of Cerebral Palsy patients with cerebral malformations, total (000s)
  • Number of Cerebral Palsy patients with congenital heart disease, total (000s)
  • Number of Cerebral Palsy patients with gastrointestinal malformations, total (000s)
  • Number of Cerebral Palsy patients with genitourinary malformations, total (000s)
  • Abbreviations and acronyms used in the report
  • USA Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • USA Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • France Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • France Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • Germany Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • Germany Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • Italy Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • Italy Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • Spain Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • Spain Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
  • Japan Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
  • Japan Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
Back to Top